Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sikarin PCLBKK:SKR-R -0.63%90 Equity-to-Asset is 0.83 as of Jun. 2026, which is 24% above its 10-year median of 0.67. GuruFocus rates BKK:SKR-R with a GF Score™ of 90/100 and a GF Value™ of ฿8.11 (Fairly Valued). The stock has 5 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Sikarin PCL ranks better than 88.92% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sikarin PCL's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ฿7,700 Mil. Sikarin PCL's Total Assets for the quarter that ended in Jun. 2026 was ฿9,303 Mil.
Therefore, Sikarin PCL's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.83.
The historical rank and industry rank for Sikarin PCL's Equity-to-Asset or its related term are showing as below:
BKK:SKR-R'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.54 Med: 0.67 Max: 0.83
Current: 0.83
During the past 13 years, the highest Equity to Asset Ratio of Sikarin PCL was 0.83. The lowest was 0.54. And the median was 0.67.
BKK:SKR-R's Equity-to-Asset is ranked better than 88.92% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs BKK:SKR-R: 0.83
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Sikarin PCL Equity-to-Asset Related Terms
Sikarin PCL Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Sikarin PCL's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SKR-R vs HCA, THC, DVA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Sikarin PCL's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sikarin PCL Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Sikarin PCL's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Sikarin PCL's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sikarin PCL (BKK:SKR-R) has a Equity-to-Asset of 0.83 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Sikarin PCL and its competitors. This is 24% above median its historical median of 0.67. Over the past decade, Sikarin PCL's Equity-to-Asset has ranged from 0.54 to 0.83. According to the industry distribution chart, Sikarin PCL ranks #76 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 11.1%.
Is Sikarin PCL's Equity-to-Asset too high?
Sikarin PCL's current Equity-to-Asset of 0.83 is 24% above median its 10-year median of 0.67. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 0.83. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Sikarin PCL's value of 0.83 is 72.9% above this industry median. Based on the distribution chart, Sikarin PCL ranks #76 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sikarin PCL has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #76 out of 686 companies for Equity-to-Asset. This places Sikarin PCL in the top 11% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.48. Sikarin PCL's value of 0.83 is 72.9% above this benchmark. Historically, Sikarin PCL's own Equity-to-Asset has ranged from 0.54 to 0.83 over the past decade. While the company's 10-year median is 0.67 vs. the industry median of 0.48, Sikarin PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sikarin PCL's current Equity-to-Asset of 0.83 is 72.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current Equity-to-Asset is 0.83, which is 24% above median its own 10-year median of 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿8.11, compared to a current price of ฿7.85 — trading 3.2% below its estimated fair value. The current Equity-to-Asset is 0.83, which is 24% above median its 10-year median of 0.67 and 72.9% above the Healthcare Providers & Services industry median of 0.48. Sikarin PCL's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR-R), the current Equity-to-Asset is 0.83 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sikarin PCL (BKK:SKR-R) Overvalued in 2026?
Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued.
The current stock price of ฿7.85 is trading 3.2% below its estimated GF Value™ of ฿8.11.
GuruFocus considers Sikarin PCL to be Fairly Valued.
Key valuation signals for BKK:SKR-R:
Equity-to-Asset: 0.83 (24% above median its 10-year median of 0.67)
GF Value™: ฿8.11 vs. price of ฿7.85 (3.2% below fair value)
Industry Position: 72.9% above the Healthcare Providers & Services median (#76 of 686)
No single metric tells the full story. See the BKK:SKR-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
90GF Score
Get the complete analysis for BKK:SKR-R
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKR-R has been successfully added to your 
